Guidelines : Generic prescribing
Detail
Committee Recommendations
The APC support the principle that, where generic medicines are available and there is no clinical rationale for the use of a particular brand, prescribers are requested to prescribe generically.
This principle is supported by a number of national and local resources:
- BNF Guidance on Prescribing
- Brand-name Prescribing in Primary Care
- Generic vs Branded Prescribing Recommendations - Dec 2016 - updated Jan 2018
- Branded and Generic Medicines - Patient Information Leaflet - Jul 2020
In 2017 a list of the most frequently prescribed brands was presented to the APC where it was agreed that the brands would be assigned a black traffic light status. This list has not been updated but the prescribing of branded medicines is NOT supported. A list of exceptions and further information can be found here:
Generic vs Branded Prescribing Recommendations - Dec 2016 - updated Jan 2018
Please refer to this and the other resources below.
Patients already receiving branded medicines should be reviewed and switched to the generic alternative if there is no clinical rationale for the brand.
Documents
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Generic prescribing.
- No records returned.